AMY COFER: Open Payments
NPI 1831173939 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 15 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $119 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
| PFIZER INC. | 1 | $15 |
| Medtronic, Inc. | 1 | $15 |
Products named: Wegovy, OTEZLA, AIRSUPRA, Veozah, Ozempic, SHINGRIX, JARDIANCE, AREXVY.
Industry payments across GA — which companies pay providers there.
